NCT00073541View on ClinicalTrials.gov

A Study of the Safety and Effects of EMD 72000 in Subjects With Recurrent Ovarian Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

March 31, 2004

Study Completion Date

August 31, 2004

Conditions
Ovarian Cancer
Interventions
DRUG

EMD 72000

Trial Locations (5)

Unknown

Baltimore

Boston

New York

Charlotte

Nashville

Sponsors

Lead Sponsor

EMD Serono
All Listed Sponsors
lead

EMD Serono

INDUSTRY

NCT00073541 - A Study of the Safety and Effects of EMD 72000 in Subjects With Recurrent Ovarian Cancer | Biotech Hunter | Biotech Hunter